Protocol for a Double-Blind Randomized Pilot Trial on the Augmentative Effect of Transcranial Alternating Current Stimulation Combined with Maintenance Medication in Adolescents with Major Depressive Disorder
Background: Adolescent major depressive disorder (MDD) is associated with substantial functional impairment and represents a major public health concern. Although pharmacotherapy and psychotherapy are established treatments, a considerable proportion of adolescents experience inadequate treatment response, adverse effects, or poor adherence. Transcranial alternating current stimulation (tACS) is an emerging non-invasive neuromodulation approach with potential therapeutic benefits; however, its feasibility, safety, and preliminary clinical effects in adolescents with MDD remain insufficiently investigated. This study will evaluate the feasibility, safety, and preliminary clinical outcomes of adjunctive tACS treatment in adolescents with MDD. Methods: This randomized, double-blind, sham-controlled pilot trial will enroll 30 adolescents aged 12–18 years with MDD, who will be randomly assigned in a 1:1 ratio to receive active or sham stimulation. Participants will undergo a 4-week intervention phase consisting of 20 stimulation sessions, followed by a 12-week follow-up phase, resulting in a total study duration of 16 weeks. Feasibility outcomes will include recruitment performance, treatment completion, and participant retention throughout the study period. Safety will be evaluated through systematic monitoring and recording of adverse events and serious adverse events. Exploratory clinical outcomes will include CDRS-R-defined response and remission, as well as changes in depressive symptoms, anxiety, suicidality, sleep quality, Clinical Global Impression scores, rumination, and health-related quality of life. Exploratory assessments will examine cognitive, neurophysiological, and behavioral changes associated with tACS treatment. Discussion: This pilot trial will provide preliminary evidence regarding the feasibility, acceptability, and safety of adjunctive tACS treatment for adolescents with MDD. The findings will help estimate potential clinical effects and inform the design of a future adequately powered randomized controlled trial.
Authors
- Xinyu Zhou (ORCID: https://orcid.org/0000-0003-1908-0357)
- Ningyi Wan (ORCID: https://orcid.org/0009-0004-9915-4452)
- DanYu Xu
- Xiao Li (ORCID: https://orcid.org/0000-0002-6120-3800)
- Li Zhang (ORCID: https://orcid.org/0000-0003-3030-565X)
- Tian Qiu (ORCID: https://orcid.org/0000-0003-4104-7238)
- Wenjing Wang (ORCID: https://orcid.org/0009-0005-7812-9036)
- Hongyi Chen
- Yuhuan Wei
- Xinyin Luo
- Xiaocong Jiang
- Xuemei Li
- Ting Wang
Institutions
- Second Affiliated Hospital of Chongqing Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
Publication Details
- Journal
- Healthcare
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/healthcare14223972
- Primary Topic
- Transcranial Magnetic Stimulation Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00